Casper Pharma is an emerging specialty pharmaceutical company focused on improving patients' lives by leveraging its global network to develop, acquire and commercialize pharmaceuticals that fulfill medical needs for the cardiovascular, gastrointestinal, urological, pain management and ophthalmic markets.
Casper’s mission is to leverage innovation, technology, and its global pharmaceutical network to improve the health of patients and fulfill medical needs.
Casper strives to become a leading, fully integrated, specialty pharmaceutical company that provides medications that improves and extends patient lives.
The Casper Pharma team is comprised of proven senior executives with extensive pharmaceutical commercial, development and transaction expertise.
Through innovation, we identify the unmet needs of patients in the delivery of medication, and fill those gaps to improve patient outcomes.
With integrity, Casper interfaces with healthcare practitioners to provide education and information to help improve healthcare.
With passion, we attack the challenges we face in treating diseases that negatively affect the quality of patient’s lives.
We demonstrate our commitment to the healthcare community by building a portfolio of high quality, cost effective, value-added therapies that serve our customers’ needs.
Casper Pharma’s products cover a number of therapeutic categories, including cardiovascular, gastrointestinal, urological, pain management and ophthalmic, where there is a sustained medical need.
(BUSINESSWIRE) – Casper Pharma, an emerging specialty brand pharmaceutical company, announced the following recent executive appointments for three senior roles.